Loading...
Chemical structure of R-10015

GC65207

R-10015

Also known as methyl 2-[1-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]-3H-benzimidazole-5-carboxylate

R-10015, a broad-spectrum antiviral compound for HIV infection, acts as a potent and selective inhibitor of LIM domain kinase (LIMK) and binds to the ATP-binding pocket, with an IC50 of 38 nM for human LIMK1

ChemicalCAS2097938-51-5MW410.86FormulaC20H19ClN6O2
CAS number
2097938-51-5
Molecular weight
410.86
Formula
C20H19ClN6O2
Solubility
DMSO : 62·5 mg/mL (152·12 mM; Need ultrasonic)
InChIKey
MGRJCGXCUUCOQG-UHFFFAOYSA-N
Catalogue number
GC65207
Brand
GLPBIO
Computed properties PubChem CID 129896912 · XLogP 3.4 · TPSA 99.8 Ų · H-bond donors 2
XLogP
3.4
TPSA
99.8 Ų
H-bond donors
2
H-bond acceptors
6
Rotatable bonds
4
Heavy atoms
29

SMILES COC(=O)C1=CC2=C(C=C1)N=C(N2)C3CCN(CC3)C4=NC=NC5=C4C(=CN5)Cl

Computed descriptors from PubChem (CID 129896912), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.